Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Archive Search

1 results
3:44 PM, Oct 30, 2017  |  BC Extra | Company News

Novartis offers $3.9B to acquire Advanced Accelerator

includes several radiotherapeutic products, including preclinical prostate cancer candidate 177Lu PSMA-R2 and its companion diagnostic, 68GA PSMA-R2